Toxicity associated with high-dose cytosine arabinoside and total body irradiation as conditioning for allogeneic bone marrow transplantation

Bone Marrow Transplantation

Volumn 19, Issue 11, 1997, Pages 1061-1064

  Kumar, M ^a   Saleh, A ^b   Rao, P V ^c   Ochoa, S ^d   Meyers, L ^e   Miller, A ^f   Graham Pole, J ^c,e  

^a Dept Pediatrics   (United States)

^b NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d Pediat Oncol Grp Stat Office   (United States)

^e UNIVERSITY OF FLORIDA   (United States)

^f TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Allogeneic; Cytosine; Total body irradiation; Toxicity; Transplantation

Indexed keywords

ANTINEOPLASTIC AGENT; CYTARABINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGE; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER SURVIVAL; CHILD; CONDITIONING; DRUG MEGADOSE; DRUG TOXICITY; FEMALE; GENDER; GRAFT VERSUS HOST REACTION; HISTOCOMPATIBILITY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA; LIVER TOXICITY; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RELAPSE; RISK; RISK FACTOR; SEPSIS; WHOLE BODY RADIATION;

EID: 0030972781     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700797     Document Type: Article

References (21)

1. Johnson FL, Thomas ED, Clark BS et al. A comparison of marrow transplantation with chemotherapy for children with acute lymphoblastic leukemia in second or subsequent remission. New Engl J Med 1981; 305: 846-851.
2. Weisdorf DJ, Nesbit ME, Ramsay NKC et al. Allogeneic bone marrow transplantation for acute lymphoblastic leukemia in remission: prolonged survival associated with acute graft versus host disease. J Clin Oncol 1987; 5: 1348-1355.
3. Brochstein JA, Kernan NA, Groshen S et al. Allogeneic bone marrow transplantation after hyperfractionated total body irradiation and cyclophosphamide in children with acute leukemia. New Engl J Med 1987; 317: 1618-1624.
4. Coccia PF, Strandford SE, Warkentin PI et al. High dose cytosine arabinoside and fractionated total body irradiation: an improved preparative regimen for bone marrow transplantation in children with acute lymphoblastic leukemia in remission. Blood 1988; 71: 888-893.
5. Blume KG, Forman SJ, O'Donnell MR et al. Total body irradiation and high dose etoposide: a new preparative regimen for bone marrow transplantation in patients with advanced hematological malignancies. Blood 1987; 69: 1015-1020.
6. Ratanatharathorn V, Karanes C, Lum LG. Allogeneic bone marrow transplantation in high risk myeloid disorders using busulphan, cytosine arabinoside and cyclophosphamide (BAC). Bone Marrow Transplant 1992; 9: 49-55.
7. Herzig HR, Wolff SN, Lazarus HM et al. High dose cytosine arabinoside therapy for refractory leukemia. Blood 1983; 62: 361-369.
8. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. Wiley: New York, 1980.
9. Lee ET. Statistical Methods for Survival Data Analysis. Wiley: New York, 1992.
10. SAS user's guide. Statistics, version 6.1. SAS Institute: Cary, NC.
11. Riddell S, Applebaum FR, Buckner CD et al. High dose cytarabine and total body irradiation with or without cyclophosphamide as a preparative regimen for marrow transplantation for acute leukemia. J Clin Oncol 1988; 6: 576-582.
12. Andersson BS, Luna MA, Yee C et al. Fatal pulmonary failure complicating high dose cytosine arabinoside therapy in acute leukemia. Cancer 1990; 65: 1079-1084.
13. Vogler WR, Winton EF, Heffner LT et al. Ophthalmological and other toxicities related to cytosine arabinoside and total body irradiation as preparative regimen for bone marrow transplantation. Bone Marrow Transplant 1990; 6: 405-409.
14. Bearman SL, Applebaum FL, Back A et al. Regimen related toxicity and early post transplant survival in patients undergoing marrow transplantation for lymphoma. J Clin Oncol 1989; 7: 1288-1294.
15. Woods WG, Ramsay NKC, Weisdorf DJ et al. Bone marrow transplantation for acute lymphoblastic leukemia utilizing total body irradiation followed by high dose of cytosine arabinoside: lack of superiority over cyclophosphamide containing conditioning regimens. Bone Marrow Transplant 1990; 6: 9-16.
16. Weyman C, Graham-Pole J, Emerson S et al. Use of cytosine arabinoside and total body irradiation as conditioning for allogeneic bone marrow transplantation in patients with acute lymphoblastic leukemia: a multicenter survey. Bone Marrow Transplant 1993; 11: 43-50.
17. Gale RP, Kersey JH, Bortin MM et al. Bone marrow transplantation for acute lymphoblastic leukemia. Lancet 1983: II: 663-667.
18. Weisdorf DJ, McGlave PB, Ramsay NKC et al. Allogeneic bone marrow transplantation for acute leukemias: comparative outcomes for adults and children. Br J Haematol 1988; 69: 351-358.
19. Hoelzer D, Gale RP. Acute lymphoblastic leukemia in adults: recent progress, future directions. Semin Hematol 1987; 24: 27-39.
20. Blume KG, Forman SJ, Nademance AP et al. Bone marrow transplantation for hematological malignancies in patients aged 30 years and older. J Clin Oncol 1986; 4: 1489-1492.
21. Herzig RH, Coccia PF, Lazarus HM et al. Bone marrow transplantation for acute leukemia and lymphoma with high-dose cytosine arabinoside and total body irradiation. Semin Oncol 1985; 12: 184-186.